Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Operating Leases (2020 - 2024)

Pharma-Bio Serv filings provide 5 years of Operating Leases readings, the most recent being $28834.0 for Q4 2024.

  • On a quarterly basis, Operating Leases fell 85.14% to $28834.0 in Q4 2024 year-over-year; TTM through Oct 2024 was $28834.0, a 85.14% decrease, with the full-year FY2024 number at $28834.0, down 85.14% from a year prior.
  • Operating Leases hit $28834.0 in Q4 2024 for Pharma-Bio Serv, down from $71362.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $729389.0 in Q1 2020 to a low of $28834.0 in Q4 2024.
  • Median Operating Leases over the past 5 years was $400460.0 (2022), compared with a mean of $393144.6.
  • Biggest five-year swings in Operating Leases: decreased 18.42% in 2021 and later tumbled 85.14% in 2024.
  • Pharma-Bio Serv's Operating Leases stood at $629979.0 in 2020, then fell by 22.64% to $487364.0 in 2021, then decreased by 28.9% to $346509.0 in 2022, then crashed by 44.0% to $194035.0 in 2023, then tumbled by 85.14% to $28834.0 in 2024.
  • The last three reported values for Operating Leases were $28834.0 (Q4 2024), $71362.0 (Q3 2024), and $113044.0 (Q2 2024) per Business Quant data.